Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2161 to 2175 of 7682 results

  1. Electrosurgery (diathermy and coblation) for tonsillectomy, (IP324/2)

      Status ...

  2. Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations TSID 12011

      Status ...

  3. Pembrolizumab adjuvant for urothelial carcinoma and/or localised muscle invasive bladder cancer TSID 12021

    Awaiting development [GID-TA11556] Expected publication date: TBC

  4. Niraparib with abiraterone acetate and prednisone for treating hormone-sensitive metastatic prostate cancer TSID 12044

    Awaiting development [GID-TA11558] Expected publication date: TBC

  5. Nirogacestat for treating desmoid tumours TSID 12039

    Awaiting development [GID-TA11559] Expected publication date: TBC

  6. Insertion of a Catheter based intravascular microaxial blood pump for acute heart failure

    Awaiting development [GID-IPG10404] Expected publication date: TBC

  7. In-situ Normothermic Regional Perfusion system for DCD donors

    Awaiting development [GID-IPG10405] Expected publication date: TBC

  8. Insertion of neo-chordae into the beating heart for mitral regurgitation

    In development [GID-IPG10216] Expected publication date: TBC

  9. Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia

      Status ...

  10. High linear energy transfer radiation for carbon ion beam therapy

    Register an interest in this interventional procedure   ...

  11. Differential Target Multiplexed Spinal Cord Stimulation (MT742)

      Status ...

  12. Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]

    Awaiting development [GID-TA11025] Expected publication date: TBC

  13. Tislelizumab with chemotherapy for untreated unresectable or metastatic gastric or gastro-oesophageal junction cancer [ID6157]

    Awaiting development [GID-TA11092] Expected publication date: TBC

  14. Tislelizumab with platinum-based chemotherapy and etoposide for untreated extensive-stage small-cell lung cancer [ID6158]

    Awaiting development [GID-TA11094] Expected publication date: TBC